| Peer-Reviewed

Mid-Term Outcomes of Beating Heart Mitral Valve Replacement in Secondary Mitral Regurgitation with Poor Left Ventricular Function

Received: 15 March 2023    Accepted: 3 April 2023    Published: 10 June 2023
Views:       Downloads:
Abstract

Background: Ischemic cardiomyopathy patients often have a severely atherosclerotic ascending aorta and low cardiac function. In these patients, aortic cross-clamping and cardiac arrest increase the risk of postoperative strokes and low cardiac output syndrome. Objective: To evaluate the short and medium term outcomes of clampless beating heart mitral valve replacement in patients with secondary mitral regurgitation and a poor left ventricular function. Method: Here we describe two male patients, aged 71 and 54 years, with severe secondary mitral regurgitation and impaired left ventricular ejection fraction (LVEF) (24% and 30%, respectively). On-pump beating-heart mitral valve replacement with total chordal sparing was performed without aortic cross-clamping, through a full sternotomy approach. Results: Weaning from cardiopulmonary bypass, which lasted 43 and 52 minutes respectively, was easily achieved without the use of positive inotropes or vasopressors. The duration of mechanical ventilation (3 and 6 hours, respectively) and intensive care (24 and 48 hours, respectively) was short, considering the advanced stage of cardiomyopathy. Both patients had no postoperative neurological disorder. After a mean follow-up of 66 months (84 and 48 months, respectively), both patients were asymptomatic, without prosthetic valve dysfunction and their LVEF reached 42% and 51%, respectively. Conclusion: Beating heart mitral valve replacement, with total preservation of subvalvular apparatus, and without cross-clamping of the aorta, preserves left ventricular systolic function in the short and long-term, and reduces embolic events due to aortic manipulation. This technique can improve the outcomes of surgery for secondary mitral regurgitation in cases of severe left ventricular dysfunction.

Published in International Journal of Cardiovascular and Thoracic Surgery (Volume 9, Issue 3)
DOI 10.11648/j.ijcts.20230903.11
Page(s) 22-26
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Heart Failure, Dilated Cardiomyopathy, Mitral Regurgitation, Beating Heart

References
[1] Alec Vahanian, Friedhelm Beyersdorf, Fabien Praz, et al, ESC/EACTS Scientific Document Group, ESC National Cardiac Societies, 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal, Volume 43, Issue 7, 14 February 2022, Pages 561–632, https://doi.org/10.1093/eurheartj/ehab395.
[2] Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005; 45: 381-387. doi: 10.1016/j.jacc.2004.09.073.
[3] Goldstein D, Moskowitz A, Gelijns A. Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med. 2016 Jan 28; 374 (4): 344-53. doi: 10.1056/NEJMoa1512913.
[4] Abah U, Roberts G, Ishaq M, De Silva R. Is cold or warm blood cardioplegia superior for myocardial protection? Interact Cardiovasc Thorac Surg 2012; 14: 848-855 doi: 10.1093/ icvts/ ivs069.
[5] Decoene C. La cardioplégie sanguine: avantages et inconvénients [Blood cardioplegia: advantages and disadvantages]. Ann Fr Anesth Reanim. 2011 May; 30 Suppl 1: S20-2. French. doi: 10.1016/S0750-7658(11)70004-1. PMID: 21703481.
[6] Salhiyyah. K, Taggart. D. Beating-heart Valve Surgery: A Systematic Review. Asian Cardiovasc Thorac Ann 2009; 17: 650–8. doi: 10.1177/0218492309348942.
[7] Calafiore AM, Di Mauro M, Teodori G, et al. Impact of aortic manipulation on incidence of cerebrovascular accidents after surgical myocardial revascularization. Ann Thorac Surg. 2002 May; 73 (5): 1387-93. doi: 10.1016/s0003-4975(02)03470-7. PMID: 12022522.
[8] Weman SM, Karhunen PJ, Penttila A, Jarvinen AA, Salminen US. Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting. Ann Thorac Surg 2000; 70: 807-12. doi: https://doi.org/10.1016/S0003-4975(00)01638-6.
[9] Mehlhorn U, Allen SJ, Adamus DL, Davis KL, Gogola GR, Warters RD. Cardiac surgical conditions induced by β-blockade: effect on myocardial fluid balance. Ann Thorac Surg 1996; 62: 143–50. doi: 10.1016/0003-4975(96)00221-4.
[10] Matsumoto Y, Watanabe G, Endo M, et al. Efficacy and safety of on-pump beating heart surgery for valvular disease. Ann Thorac Surg 2002; 74: 678-683 doi: 10.1016/S0003-4975(02)03753-0.
[11] Calcaterra D, Ricci M, Salerno TA. A new technique for perfusion of the heart during aortic valvular surgery on a beating heart. J Card Surg 2007; 22: 432-33. doi: 10.1111/j.1540-8191.2007.00443.x.
[12] Wang J, Liu H, Salerno TA, et al. Keeping heart empty and beating improves preservation of hypertrophied hearts for valve surgery. J Thorac Cardiovasc Surg 2006; 132: 1314-20). doi: 10.1016/j.jtcvs.2006.07.010.
[13] Romano M, Haft J, Pagani F, Bolling S. Beating heart surgery via right thoracotomy for reoperative mitral valve surgery: a safe and effective operative alternative. J Thorac Cardiovasc Surg. 2012 Aug; 144 (2): 334-9. doi: 10.1016/j.jtcvs.2011.09.026.
[14] Pasic. M, Sundermann. S, Unbehaun. A, Kempfert. J, Jacobs. S, Falk. V. Beating heart mitral valve surgery: results in 120 consecutive patients considered unsuitable for conventional mitral valve surgery Interactive CardioVascular and Thoracic Surgery 25 (2017) 541-547. Doi: 10.1093/ icvts/ ivx139.
[15] Babaroglu. S, Yay. K, Parlar. A et al Beating heart versus conventional mitral valve surgery Interact CardioVasc Thorac Surg 2011; 12: 441-7. Doi; 10.1510/icvts.2010.255240.
[16] Ghosh S, Jutley RS, Wraighte P, Shajar M, Naik SK. Beating-heart mitral valve surgery in patients with poor left ventricular function. J Heart Valve Dis. 2004 Jul; 13 (4): 622-7; discussion 627-9. PMID: 15311869.
[17] Hausmann H, Siniawski H, Hetzer R. Mitral valve reconstruction and replacement for ischemic mitral insufficiency: seven years' follow up. J Heart Valve Dis. 1999 Sep; 8 (5): 536-42. PMID: 10517396.
[18] Zhang, H., Xu, Hs., Wen, B. et al. Minimally invasive beating heart technique for mitral valve surgery in patients with previous sternotomy and giant left ventricle. J Cardiothorac Surg 15, 122 (2020). https://doi.org/10.1186/s13019-020-01171-6
[19] Bolcal, C, Kadan, M, Erol, G, et al. Robotic-assisted beating heart mitral valve surgery: Preliminary report. J Card Surg. 2022; 37: 4790-4796. doi: 10.1111/jocs.17124.
[20] Salerno TA, Suarez M, Panos AL, et al. Results of beating heart mitral valve surgery via the trans-septal approach. Rev Bras Cir Cardiovasc. 2009 Jan-Mar; 24 (1): 4-10. doi: 10.1590/s0102-76382009000100003. PMID: 19504012.
[21] Ricci. M, Macedo. F, Suarez. M, Brown. M, Alba. J, Salerno. T. Multiple Valve Surgery with Beating Heart Technique. Ann Thorac Surg 2009; 87: 527-31. doi: 10.1016/j.athoracsur.2008.10.030.
[22] Karadeniz. U, Erdemli O, Yamak B et al. On-pump beating heart versus hypothermic arrested heart valve replacement surgery. J Card Surg. 2008 Mar-Apr; 23 (2): 107-13 doi: 10.1111/j.1540-8191.2007.00536.x.
[23] Kervan. U, Cicekcioglu F, Tuluce H et al. Comparison of neurocognitive functions after beating-heart mitral valve replacement without aorta cross-clamping and after standard mitral valve replacement with cardioplegic arrest. Heart Surg Forum. 2011 Dec; 14 (6): E335-9 doi: 10.1532/HSF98.20101173.
[24] Sá. M. P. B. O, Ferraz. P, Escobar. R et al. Preservation versus non-preservation of mitral valve apparatus during mitral valve replacement: a meta-analysis of 3835 patients. Interactive CardioVascular and Thoracic Surgery 15 (2012) 1033-1039 doi: 10.1093/icvts/ivs379.
[25] Yun. K, Sintek. C, Miller. D et al. Randomized trial comparing partial versus complete chordal-sparing mitral valve replacement: Effects on left ventricular volume and fonction. J Thorac Cardiovasc Surg 2002; 123: 707-14). Doi: 10.1067/mtc.2002.121048.
[26] D'Onofrio, A, Fiocco, A, Nadali, M, Gerosa, G. Transapical mitral valve repair procedures: primetime for microinvasive mitral valve surgery. J Card Surg. 2022; 37: 4053-4061. https://doi.org/10.1111/jocs.16011
Cite This Article
  • APA Style

    Abdelkader Boukhmis, Mohammed El-Amin Nouar, Yacine Djouaher. (2023). Mid-Term Outcomes of Beating Heart Mitral Valve Replacement in Secondary Mitral Regurgitation with Poor Left Ventricular Function. International Journal of Cardiovascular and Thoracic Surgery, 9(3), 22-26. https://doi.org/10.11648/j.ijcts.20230903.11

    Copy | Download

    ACS Style

    Abdelkader Boukhmis; Mohammed El-Amin Nouar; Yacine Djouaher. Mid-Term Outcomes of Beating Heart Mitral Valve Replacement in Secondary Mitral Regurgitation with Poor Left Ventricular Function. Int. J. Cardiovasc. Thorac. Surg. 2023, 9(3), 22-26. doi: 10.11648/j.ijcts.20230903.11

    Copy | Download

    AMA Style

    Abdelkader Boukhmis, Mohammed El-Amin Nouar, Yacine Djouaher. Mid-Term Outcomes of Beating Heart Mitral Valve Replacement in Secondary Mitral Regurgitation with Poor Left Ventricular Function. Int J Cardiovasc Thorac Surg. 2023;9(3):22-26. doi: 10.11648/j.ijcts.20230903.11

    Copy | Download

  • @article{10.11648/j.ijcts.20230903.11,
      author = {Abdelkader Boukhmis and Mohammed El-Amin Nouar and Yacine Djouaher},
      title = {Mid-Term Outcomes of Beating Heart Mitral Valve Replacement in Secondary Mitral Regurgitation with Poor Left Ventricular Function},
      journal = {International Journal of Cardiovascular and Thoracic Surgery},
      volume = {9},
      number = {3},
      pages = {22-26},
      doi = {10.11648/j.ijcts.20230903.11},
      url = {https://doi.org/10.11648/j.ijcts.20230903.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcts.20230903.11},
      abstract = {Background: Ischemic cardiomyopathy patients often have a severely atherosclerotic ascending aorta and low cardiac function. In these patients, aortic cross-clamping and cardiac arrest increase the risk of postoperative strokes and low cardiac output syndrome. Objective: To evaluate the short and medium term outcomes of clampless beating heart mitral valve replacement in patients with secondary mitral regurgitation and a poor left ventricular function. Method: Here we describe two male patients, aged 71 and 54 years, with severe secondary mitral regurgitation and impaired left ventricular ejection fraction (LVEF) (24% and 30%, respectively). On-pump beating-heart mitral valve replacement with total chordal sparing was performed without aortic cross-clamping, through a full sternotomy approach. Results: Weaning from cardiopulmonary bypass, which lasted 43 and 52 minutes respectively, was easily achieved without the use of positive inotropes or vasopressors. The duration of mechanical ventilation (3 and 6 hours, respectively) and intensive care (24 and 48 hours, respectively) was short, considering the advanced stage of cardiomyopathy. Both patients had no postoperative neurological disorder. After a mean follow-up of 66 months (84 and 48 months, respectively), both patients were asymptomatic, without prosthetic valve dysfunction and their LVEF reached 42% and 51%, respectively. Conclusion: Beating heart mitral valve replacement, with total preservation of subvalvular apparatus, and without cross-clamping of the aorta, preserves left ventricular systolic function in the short and long-term, and reduces embolic events due to aortic manipulation. This technique can improve the outcomes of surgery for secondary mitral regurgitation in cases of severe left ventricular dysfunction.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Mid-Term Outcomes of Beating Heart Mitral Valve Replacement in Secondary Mitral Regurgitation with Poor Left Ventricular Function
    AU  - Abdelkader Boukhmis
    AU  - Mohammed El-Amin Nouar
    AU  - Yacine Djouaher
    Y1  - 2023/06/10
    PY  - 2023
    N1  - https://doi.org/10.11648/j.ijcts.20230903.11
    DO  - 10.11648/j.ijcts.20230903.11
    T2  - International Journal of Cardiovascular and Thoracic Surgery
    JF  - International Journal of Cardiovascular and Thoracic Surgery
    JO  - International Journal of Cardiovascular and Thoracic Surgery
    SP  - 22
    EP  - 26
    PB  - Science Publishing Group
    SN  - 2575-4882
    UR  - https://doi.org/10.11648/j.ijcts.20230903.11
    AB  - Background: Ischemic cardiomyopathy patients often have a severely atherosclerotic ascending aorta and low cardiac function. In these patients, aortic cross-clamping and cardiac arrest increase the risk of postoperative strokes and low cardiac output syndrome. Objective: To evaluate the short and medium term outcomes of clampless beating heart mitral valve replacement in patients with secondary mitral regurgitation and a poor left ventricular function. Method: Here we describe two male patients, aged 71 and 54 years, with severe secondary mitral regurgitation and impaired left ventricular ejection fraction (LVEF) (24% and 30%, respectively). On-pump beating-heart mitral valve replacement with total chordal sparing was performed without aortic cross-clamping, through a full sternotomy approach. Results: Weaning from cardiopulmonary bypass, which lasted 43 and 52 minutes respectively, was easily achieved without the use of positive inotropes or vasopressors. The duration of mechanical ventilation (3 and 6 hours, respectively) and intensive care (24 and 48 hours, respectively) was short, considering the advanced stage of cardiomyopathy. Both patients had no postoperative neurological disorder. After a mean follow-up of 66 months (84 and 48 months, respectively), both patients were asymptomatic, without prosthetic valve dysfunction and their LVEF reached 42% and 51%, respectively. Conclusion: Beating heart mitral valve replacement, with total preservation of subvalvular apparatus, and without cross-clamping of the aorta, preserves left ventricular systolic function in the short and long-term, and reduces embolic events due to aortic manipulation. This technique can improve the outcomes of surgery for secondary mitral regurgitation in cases of severe left ventricular dysfunction.
    VL  - 9
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Department Corresponding to the Working Group, Department of Cardiac Surgery, University Hospital Center Mustapha, Algiers, Algeria

  • Department Corresponding to the Working Group, Department of Cardiac Surgery, University Hospital Center Mustapha, Algiers, Algeria

  • Department Corresponding to the Working Group, Department of Cardiac Surgery, University Hospital Center Mustapha, Algiers, Algeria

  • Sections